Breaking News Instant updates and real-time market news.

ALC

Alcon

$56.68

-0.37 (-0.65%)

, DGLY

Digital Ally

$4.23

-0.13 (-2.98%)

08:30
04/18/19
04/18
08:30
04/18/19
08:30

Five new option listings and five option delistings on April 18th

New option listings for April 18th include Alcon Inc (ALC), Christopher and Banks Corp (CBKC), Digital Ally (DGLY), Intellicheck (IDN), and Social Realty (SRAX). Option delistings effective April 18th include Belmond Ltd (BEL), Christopher and Banks Corp (CBK), Ellie Mae Inc (ELLI), Goldcorp Inc (GG), and Osiris Therapeutics Inc (OSIR).

ALC

Alcon

$56.68

-0.37 (-0.65%)

DGLY

Digital Ally

$4.23

-0.13 (-2.98%)

IDN

Intellicheck

$3.14

(0.00%)

SRAX

SRAX, Inc

$4.99

-0.04 (-0.80%)

BEL

Belmond

$25.00

(0.00%)

CBK

Christopher & Banks

$0.00

(0.00%)

ELLI

Ellie Mae

$98.99

(0.00%)

GG

Goldcorp

$11.23

-0.13 (-1.14%)

OSIR

Osiris

$19.00

(0.00%)

  • 30

    Apr

  • 08

    May

  • 30

    May

ALC Alcon
$56.68

-0.37 (-0.65%)

04/11/19
SOCG
04/11/19
DOWNGRADE
SOCG
Sell
Societe Generale corrects error in work, downgrades Alcon to Sell
Societe Generale analyst Delphine Le Louet, who initiated Alcon yesterday with a Buy rating and CHF67 price target, said she identified an error in her model and has downgraded the stock to Sell from Buy after correcting her work. Her corrected discounted cash flow valuation analysis leads her to a new price target of CHF44, said the analyst, who apologized for the error and noted she made no changes to her P&L forecasts.
04/15/19
JEFF
04/15/19
INITIATION
Target $70
JEFF
Buy
Alcon initiated with a Buy at Jefferies
Jefferies analyst Anthony Petrone started Alcon with a Buy rating and $70 price target. The analyst's consumer work points toward a $400M-$600M opportunity for Precision1 while his doctor survey points toward a $200M-$300M opportunity for PanOptix. He sees these and other drivers pushing Alcon's sales growth toward 6%.
04/15/19
04/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pinterest (PINS) initiated with a Neutral at DA Davidson. 2. Five Below (FIVE) initiated with a Buy at BofA/Merrill. 3. Levi Strauss (LEVI) initiated with an Outperform at Telsey Advisory, an Overweight at JPMorgan, a Buy at Citi and Guggenheim, an Equal Weight at Morgan Stanley, and a Neutral at Goldman Sachs and BofA/Merrill. 4. Tocagen (TOCA) initiated with a Market Perform at SVB Leerink. 5. Alcon (ALC) initiated with a Buy at Jefferies, while Allergan (AGN) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
BMOC
04/18/19
INITIATION
Target $54
BMOC
Market Perform
Alcon initiated with a Market Perform at BMO Capital
BMO Capital analyst Joanne Wuensch started Alcon with a Market Perform rating and $54 price target. The analyst, who views the company's end markets as "massive" with favorable demographics, is not a fan of the current valuation and prefers to wait for a better entry point.
DGLY Digital Ally
$4.23

-0.13 (-2.98%)

IDN Intellicheck
$3.14

(0.00%)

08/15/18
OPCO
08/15/18
DOWNGRADE
OPCO
Perform
Intellicheck downgraded to Perform from Outperform at Oppenheimer
08/15/18
OPCO
08/15/18
DOWNGRADE
OPCO
Perform
Intellicheck downgraded to Perform after quarterly results at Oppenheimer
Oppenheimer analyst Shaul Eyal downgraded Intellicheck to Perform from Outperform, following Q2 results that fell below his revenue estimate. While the analyst believes Intellicheck is making decent progress with its sales reorganization initiatives, these transitions tend to have a lumpy impact on execution, driving revenue unpredictability. The company's shift to a SaaS revenue model, which has exhibited moderated growth in recent quarters, remains impacted by its declining non-SaaS business, he adds.
SRAX SRAX, Inc
$4.99

-0.04 (-0.80%)

BEL Belmond
$25.00

(0.00%)

08/10/18
JEFF
08/10/18
UPGRADE
Target $20
JEFF
Buy
Belmond upgraded to Buy from Hold at Jefferies
Jefferies analyst David Katz upgraded Belmond to Buy and raised his price target for the shares to $20 from $13. With the company reviewing strategic alternatives, the analyst shifted the balance of his valuation perspective from the operating productivity to asset market value. Katz sees a high probability of a sale of Belmond given the quality of the company's assets. He believes such a deal could drive further upside in the stock.
12/17/18
JEFF
12/17/18
DOWNGRADE
Target $25
JEFF
Hold
Belmond downgraded to Hold from Buy at Jefferies
Jefferies analyst David Katz downgraded Belmond (BEL) to Hold while raising his price target for the shares to $25 from $22 following LVMH's (LVMUY) acquisition proposal. The analyst believes the proposed price will be the ultimate clearing price for the transaction. He sees a low likelihood of a further unsolicited bid coming forward.
08/17/18
LEHM
08/17/18
NO CHANGE
Target $11
LEHM
Underweight
Belmond price target raised to $15, remains Underweight at Barclays
Barclays analyst Felicia Hendrix believes Belmond management is serious about exploring all available avenues to enhance shareholder value, including a potential sale. However, Hendrix said a scenario that does not result in a sale could result in downside and believes some shareholders may benefit from locking in some gains now given the A/B share structure. The analyst increased her net asset value estimate for Belmond to $18 from $17 and raised her price target on shares to $15 from $11, but maintains an Underweight rating especially given high expectations for the value of Belmond's real estate.
08/10/18
DBAB
08/10/18
NO CHANGE
Target $17
DBAB
Hold
Belmond price target raised to $17 from $11 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Belmond to $17 after the company said it would explore strategic alternatives. The consensus view at this point on the outcome of the process has pivoted toward an outright sale of the company, Santarelli tells investors in a research note. He keeps a Hold rating on Belmond.
CBK Christopher & Banks
$0.00

(0.00%)

ELLI Ellie Mae
$98.99

(0.00%)

02/12/19
SUSQ
02/12/19
UPGRADE
Target $99
SUSQ
Neutral
Ellie Mae upgraded to Neutral from Negative at Susquehanna
Susquehanna analyst Jack Micenko upgraded Ellie Mae to Neutral and raised his price target to $99 from $53.
02/12/19
ROTH
02/12/19
DOWNGRADE
Target $99
ROTH
Neutral
Ellie Mae downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Richard Baldry downgraded Ellie Mae to Neutral from Buy and lowered his price target to $99 from $100 after after the company announced an agreement to be acquired by Thoma Bravo for $99 per share in cash. In a research note to investors, Baldry says that while the deal includes a 35 day "go-shop" period, he sees little likelihood of a competing offer given the company's track record for "staccato" execution under its management team.
02/14/19
WBLR
02/14/19
DOWNGRADE
WBLR
Market Perform
Ellie Mae downgraded to Market Perform from Outperform at William Blair
William Blair analyst Stephen Sheldon downgraded Ellie Mae to Market Perform from Outperform following the company's report of "mixed" Q4 results, stating that he sees a high likelihood of the go private deal with Thoma Bravo closing.
02/15/19
RBCM
02/15/19
NO CHANGE
Target $99
RBCM
Sector Perform
Ellie Mae price target raised to $99 from $80 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Ellie Mae to $99 after its mixed Q4 results and the announcement of being acquired by Thoma Bravo at $99 per share. The analyst sees low probability of a competitive bid emerging in the 35-day go-shop period.
GG Goldcorp
$11.23

-0.13 (-1.14%)

02/26/19
RBCM
02/26/19
DOWNGRADE
RBCM
Sector Perform
Goldcorp downgraded to Sector Perform from Outperform at RBC Capital
04/09/19
LEHM
04/09/19
NO CHANGE
LEHM
Barclays still positive on Metals and Mining, downgrades three on valuation
Barclays analyst Matthew Murphy remains positive on shares in the North America Metals and Mining space. The potential for higher recession probabilities could still drive demand for "safe assets," Murphy tells investors in a research note. Further, copper should benefit from a sequential acceleration in China during Q2, says the analyst. He sees several names with "significant upside" and "catalyst potential" including Teck Resources (TECK), Barrick Gold (GOLD), and Newmont Mining (NEM) and Goldcorp (GG). To reflect valuation, Murphy upgraded OceanaGold (OCANF) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Agnico Eagle (AEM), Franco-Nevada (FNV) and Wheaton Precious Metals (WPM).
04/08/19
RBCM
04/08/19
NO CHANGE
Target $39
RBCM
Underperform
Newmont Mining price target lowered to $39 from $41 at RBC Capital
RBC Capital analyst Stephen Walker lowered his price target on Newmont Mining (NEM) to $39 and kept his Underperform rating, saying that while his model has improved as a results of its Goldcorp (GG) takeover, integration risks are heightened and a re-rating would require evidence of the deal's success and benefits from the Nevada JV synergies. The analyst also lowers his FY19 and FY20 EPS to $1.23 and $1.28 from $1.34 and $1.51 respectively to reflect the integration risks, though he sees some upside to his estimates from better than expected synergies of the assets.
02/12/19
UBSW
02/12/19
DOWNGRADE
UBSW
Neutral
Goldcorp downgraded to Neutral from Buy at UBS
UBS analyst Cleve Reuckert downgraded Goldcorp (GG) to Neutral citing the pending takeover by Newmont Mining (NEM).
OSIR Osiris
$19.00

(0.00%)

TODAY'S FREE FLY STORIES

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

17:19
12/13/19
12/13
17:19
12/13/19
17:19
Hot Stocks
Live Nation, Zebra Technologies, Steris to move to S&P 500 at open on 12/23 »

Live Nation (LYV), Zebra…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BAESY

BAE Systems

$0.00

(0.00%)

17:15
12/13/19
12/13
17:15
12/13/19
17:15
Hot Stocks
BAE Systems awarded $249.15M Army contract modification »

BAE Systems was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.